Literature DB >> 26715809

Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.

Fang Yang1, Li-Zhi Lv1, Qiu-Cheng Cai1, Yi Jiang1.   

Abstract

AIM: To investigate the potential roles of enhancer of zeste homolog2 (EZH2), Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma (HCC) cell line Hep3B.
METHODS: A total of 73 patients who underwent surgical resection at Fuzong Clinical Medical College of Fujian Medical University were enrolled in this study. Hep3B cells were cultivated in RPMI 1640 medium supplemented with 10% fetal bovine serum at 37 °C. Vectors that containing cDNA of the EZH2 gene or miR-203 targeted shRNA plasmid were constructed, and then transfected into Hep3B cells. The mRNA expression of miR-203, EZH2, and Bmi-1 was analyzed using quantitative real-time polymerase chain reaction analysis, and the protein levels of EZH2 and Bmi-1 were detected by Western blot analysis. Effect of EZH2 or miR-203 on cell proliferation was observed by methyl thiazolyl tetrazolium assay, and cell apoptosis was assessed using flow cytometry. Besides, effect of EZH2 or miR-203 on tumor cell invasion was detected using Transwell assay.
RESULTS: The mRNA levels of EZH2 and Bmi-1 in HCC tissues and in Hep3B cells were significantly higher compared with those in normal samples (P < 0.01), while miR-203 level was significantly lower in HCC tissues (P < 0.01). Hep3B cells transfected with EZH2-shRNA or miR-203-shRNA showed lower expression levels of EZH2 and Bmi-1 (P < 0.05). Compared with controls, Hep3B cells transfected with EZH2-shRNA had relative slow cell proliferation, indicating that low expression of EZH2 and Bmi-1 and overexpression of miR-203 could inhibit Hep3B cell proliferation (P < 0.05). The average apoptosis rate of Hep3B cells transfected with EZH2-shRNA vector was about 18.631%, while that of Hep3B cells transfected with shRNA vector was about 5.33%, suggesting that EZH2 was down-regulated by transfecting with EZH2-shRNA, and the down-regulated EZH2 contributed to the cell apoptosis. Low expression of EZH2 and Bmi-1 and overexpression of miR-203 could reduce Hep3B cell invasion (P < 0.05).
CONCLUSION: Our study suggests that EZH2 and Bmi-1 are up-regulated while miR-203 is down-regulated in Hep3B cells. MiR-203 may contribute to the metastasis and enhance apoptosis of HCC cells by regulating EZH2 and Bmi-1. Our study may provide a theoretical basis for metastasis of HCC and targeted therapy of HCC.

Entities:  

Keywords:  Bmi-1; EZH2; Hep3B cell line; Hepatocellular carcinoma; Invasion; Proliferation; miR-203

Mesh:

Substances:

Year:  2015        PMID: 26715809      PMCID: PMC4679758          DOI: 10.3748/wjg.v21.i47.13268

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Polycomb group proteins ESC and E(Z) are present in multiple distinct complexes that undergo dynamic changes during development.

Authors:  Takehito Furuyama; Feng Tie; Peter J Harte
Journal:  Genesis       Date:  2003-02       Impact factor: 2.487

2.  Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.

Authors:  Andreas Karakatsanis; Ioannis Papaconstantinou; Maria Gazouli; Anna Lyberopoulou; George Polymeneas; Dionysios Voros
Journal:  Mol Carcinog       Date:  2011-12-27       Impact factor: 4.784

3.  Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.

Authors:  Xiaolei Li; Zhaoxu Yang; Wenjie Song; Liang Zhou; Qingjun Li; Kaishan Tao; Jingshi Zhou; Xing Wang; Zhigang Zheng; Nan You; Kefeng Dou; Haimin Li
Journal:  Int J Oncol       Date:  2013-06-26       Impact factor: 5.650

4.  Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.

Authors:  F M Raaphorst; F J van Kemenade; T Blokzijl; E Fieret; K M Hamer; D P Satijn; A P Otte; C J Meijer
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  MiR-218-targeting-Bmi-1 mediates the suppressive effect of 1,6,7-trihydroxyxanthone on liver cancer cells.

Authors:  Wei-Ming Fu; Li-Peng Tang; Xiao Zhu; Ying-Fei Lu; Yan-Ling Zhang; Wayne Yuk-Wai Lee; Hua Wang; Yang Yu; Wei-Cheng Liang; Chun-Hay Ko; Hong-Xi Xu; Hsiang-Fu Kung; Jin-Fang Zhang
Journal:  Apoptosis       Date:  2015-01       Impact factor: 4.677

Review 6.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

7.  The expression and function of microRNA-203 in lung cancer.

Authors:  Jianhua Jin; Jianzhong Deng; Fang Wang; Xiyi Xia; Tiefeng Qiu; Wenbin Lu; Xianwen Li; Hua Zhang; Xiaoyan Gu; Yungang Liu; Weiguo Cao; Wenlong Shao
Journal:  Tumour Biol       Date:  2012-10-17

8.  miR-203 inhibits proliferation of HCC cells by targeting survivin.

Authors:  Wang Wei; Liu Wanjun; Sun Hui; Chen Dongyue; Yao Xinjun; Zhao Jisheng
Journal:  Cell Biochem Funct       Date:  2012-08-10       Impact factor: 3.685

9.  Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantation.

Authors:  Yi-Chiao Cheng; Teng-Wei Chen; Hsiu-Lung Fan; Chih-Yung Yu; Heng-Cheng Chang; Chung-Bao Hsieh
Journal:  Ann Transplant       Date:  2014-06-30       Impact factor: 1.530

10.  The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).

Authors:  R Ciarapica; M De Salvo; E Carcarino; G Bracaglia; L Adesso; P P Leoncini; A Dall'Agnese; Z S Walters; F Verginelli; L De Sio; R Boldrini; A Inserra; G Bisogno; A Rosolen; R Alaggio; A Ferrari; P Collini; M Locatelli; S Stifani; I Screpanti; S Rutella; Q Yu; V E Marquez; J Shipley; S Valente; A Mai; L Miele; P L Puri; F Locatelli; D Palacios; R Rota
Journal:  Oncogene       Date:  2013-11-11       Impact factor: 9.867

View more
  12 in total

1.  MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes.

Authors:  Maria M Simile; Graziella Peitta; Maria L Tomasi; Stefania Brozzetti; Claudio F Feo; Alberto Porcu; Antonio Cigliano; Diego F Calvisi; Francesco Feo; Rosa M Pascale
Journal:  Oncotarget       Date:  2019-04-19

2.  Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma.

Authors:  Juan Wang; Zhihong Ai; Jing Chen; Yincheng Teng; Jieping Zhu
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

3.  Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis.

Authors:  Fang Qian; Wei Kong; Shuaiqun Wang; Kai Wei
Journal:  Clin Exp Med       Date:  2022-10-22       Impact factor: 5.057

Review 4.  Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.

Authors:  Yiping Wen; Jing Cai; Yaya Hou; Zaiju Huang; Zehua Wang
Journal:  Oncotarget       Date:  2017-06-06

5.  miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.

Authors:  Xiao-Bo Zheng; Xiao-Bo Chen; Liang-Liang Xu; Ming Zhang; Lei Feng; Peng-Sheng Yi; Jian-Wei Tang; Ming-Qing Xu
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

6.  Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling.

Authors:  Junlong Zhao; Huichen Li; Shoujie Zhao; Enxin Wang; Jun Zhu; Dayun Feng; Yejing Zhu; Weijia Dou; Qingling Fan; Jie Hu; Lintao Jia; Lei Liu
Journal:  Mol Cancer       Date:  2021-03-03       Impact factor: 27.401

7.  KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth.

Authors:  Yiwei Wang; Jin Zang; Dongyong Zhang; Zhenxiang Sun; Bo Qiu; Xiaojie Wang
Journal:  Onco Targets Ther       Date:  2018-01-08       Impact factor: 4.147

Review 8.  The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients.

Authors:  Li Fu; Bing Han; Yang Zhou; Jie Ren; Wenzhi Cao; Gopal Patel; Guoyin Kai; Jun Zhang
Journal:  Front Pharmacol       Date:  2020-03-19       Impact factor: 5.810

Review 9.  TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma.

Authors:  Simona Todisco; Paolo Convertini; Vito Iacobazzi; Vittoria Infantino
Journal:  Cancers (Basel)       Date:  2019-12-25       Impact factor: 6.639

10.  Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells.

Authors:  Antonella Muscella; Erika Stefàno; Luigi De Bellis; Eliana Nutricati; Carmine Negro; Santo Marsigliante
Journal:  Ann N Y Acad Sci       Date:  2021-05-07       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.